The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Central Imaging Review Analysis with mint Lesion

Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks

Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to support your study requirements with read-ready functionality quickly available.

  • Multiple read paradigms: Support for single reads, double reads with adjudication, and eligibility workflows
  • Multi-criteria reads: Apply multiple evaluation frameworks to the same image
  • Flexible templates: Use standard response criteria read templates or custom eCRFs you design
  • Built-in analytics: Volumetrics, SUVs, tumor growth rates, and radiomics capabilities
  • Automated notifications: Alerts configured to align with your review flow
  • Export functionality: One-click exports for images, data (CDISC, radiomics, observations), and structured results

 

Related Resources

Related Resources

How to improve reading procedures and reduce errors in clinical trials with imaging endpoints

Dr. Laura Oleaga from Hospital Clinìc de Barcelona explains how she and her team have benefitted from implementing mint Lesion™ in the face of an…

LMU University Hospital Munich: Real-time Data Visualization and Analysis in Clinical Ttrials with Imaging Endpoints

“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole…

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…